Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:06:09.993Z.
Calculation as of: 2026-10-06T14:06:09.993Z.
Quote observation: 2026-10-06T14:05:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 273f4a35489c6dcba82bfbf6813c8f243fa8fa5e32baf23fc33ea9a1b57f5f97
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Compass Therapeutics, Inc.
Market Cap
$177.22M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.89M
Free Cash Flow Yield
N/A
TTM Avg
0.25%
3Y Avg
0.25%
5Y Avg
0.25%
Market Cap
$172.65M
Free Cash Flow Yield
N/A
TTM Avg
12.80%
3Y Avg
12.80%
5Y Avg
12.80%
Market Cap
$179.31M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.88M
Free Cash Flow Yield
N/A
TTM Avg
7.28%
3Y Avg
8.72%
5Y Avg
8.72%
Market Cap
$165.46M
Free Cash Flow Yield
N/A
TTM Avg
0.52%
3Y Avg
0.52%
5Y Avg
7.43%
Market Cap
$191.97M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $177.22M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $178.56M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.89M | N/A | 0.25% | 0.25% | 0.25% |
| MediWound Ltd. (MDWD)vs › | $172.65M | N/A | 12.80% | 12.80% | 12.80% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.31M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $182.88M | N/A | 7.28% | 8.72% | 8.72% |
| Coherus Oncology, Inc. (CHRS)vs › | $165.46M | N/A | 0.52% | 0.52% | 7.43% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $191.97M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $159.74M | N/A | 1.49% | 2.55% | 2.12% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $160.80M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
